Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV

NCT07390474 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

NIH

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: DV201P-RNA
BIOLOGICAL: DV202B1-RNA

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)